Non-equilibrium strategies enabling ligand specificity by signaling receptors
eLife · 2025
DOI: 10.7554/elife.107524 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Andrew Goetz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Yale University, New Haven, United States. Hauptthemen laut MEDLINE: Signal Transduction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome, NIGMS NIH HHS, UK Research and Innovation.
Abstract (Originalsprache)
Signaling receptors often encounter multiple ligands and have been shown to respond selectively to generate appropriate, context-specific outcomes. At thermal equilibrium, ligand specificity is limited by the relative affinities of ligands for their receptors. Here, we present a non-equilibrium model in which receptors overcome thermodynamic constraints to preferentially signal from specific ligands while suppressing others. In our model, multi-site phosphorylation and active receptor degradation act in concert to regulate ligand specificity, with receptor degradation, a common motif in eukaryotes, providing a previously under-appreciated layer of control. Here, ligand-bound receptors undergo sequential phosphorylation, with progression restarted by ligand unbinding or receptor turnover. High-affinity complexes are kinetically sorted toward degradation-prone states, while low-affinity complexes are sorted toward inactivated states, both limiting signaling. As a result, network activity is maximized for ligands with intermediate affinities. This mechanism explains paradoxical experimental observations in receptor tyrosine kinase signaling, including non-monotonic dependence of signaling output on ligand affinity and kinase activity. Given the ubiquity of multi-site phosphorylation and ligand-induced degradation across signaling receptors, we propose that kinetic sorting may be a general non-equilibrium ligand-discrimination strategy used by multiple signaling receptors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Yale University, New Haven, United States.
- Department of Physics, Yale University, New Haven, United States.
- MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, Dundee, United Kingdom.
- Systems Biology Institute, Yale University, New Haven, United States.
ORCID-Profile: Ralitsa Radostinova Madsen, Purushottam D Dixit
Förderung
- Wellcome
- NIGMS NIH HHS
- UK Research and Innovation
- Wellcome Trust
- National Institute of General Medical Sciences
Zitieren
APA
Goetz, A., Barrios, J., Madsen, R. R., & Dixit, P. D. (2025). Non-equilibrium strategies enabling ligand specificity by signaling receptors. eLife. https://doi.org/10.7554/elife.107524
Vancouver
Goetz A, Barrios J, Madsen RR, Dixit PD. Non-equilibrium strategies enabling ligand specificity by signaling receptors. eLife. 2025. doi:10.7554/elife.107524
BibTeX
@article{Goetz2025,
author = {Goetz, Andrew and Barrios, Jeremy and Madsen, Ralitsa Radostinova and Dixit, Purushottam D},
title = {Non-equilibrium strategies enabling ligand specificity by signaling receptors},
journal = {eLife},
year = {2025},
doi = {10.7554/elife.107524}
}
EUVIMED